Serum and concentrated urine from blood donors, patients with rheumatoid arthritis and SLE patients with and without renal disease were tested for the presence of fibrinogen degradation products (FDP), using the tanned red cell hemagglutination inhibition immunoassay. The majority of blood donors had serum titers of 1:2 to 1:4, while the majority of patients with rheumatoid arthritis and systemic lupus erythematosus had titers of 1:8 to 1:32. FDP were detected in low titers in urine of nearly all blood donors, patients with rheumatoid arthritis and SLE patients without renal disease, whereas elevated titers were found in SLE patients with active renal disease. Several possible sources of the urinary FDP are discussed, and the role of fibrin deposition in glomerular injury is reviewed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.